CERT (certara.com) Company Profit

CERT (Certara Inc) - company brandmark

Certara, Inc. (CERT) relies on cloud computing for drug modeling, yet reduced biotech research spending and prolonged deal closures are weighing on profits, which are currently -0.00. This price chart clearly illustrates the asset's price action. The company's dominance in the specialized software segment makes it indispensable for pharma behemoths, providing the pricing power to flexibly manage subscription costs.

Certara (CERT): Net Profit from 07/04/2022 to 10/29/2026

Comprehensive metric breakdowns and analytics for Certara (CERT)

- stock value and consensus price forecast:
Market Price Certara Software|CERT - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Certara Software|CERT - Enterprise Value
- book capitalization information:
Accounting Value per Share Certara|CERT - Book Capitalization|Market-to-Book Ratio certara.com|CERT - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Certara, Inc.|CERT - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Certara Inc|CERT - Company Aggregate Debts|Debts to Book Capitalization Certara Software|CERT - Company Long-Term Debt|Company Short-Term Loans and Borrowings Certara|Quick Ratio certara.com
- net income and valuation ratios data:
CERT - Net Income
Fundamental valuation:Certara, Inc.
Manufactured products of certara.com

Certara, Inc. (CERT) revenues depend on the investment cycles of global pharmaceutical companies and regulatory standards. This indicator captures the final net balance of funds after deducting all operating and tax liabilities. By analyzing the company's financial results, an investor assesses the real efficiency of the monetization of biosimulation software. Sharp fluctuations in the curve signal cash flow volatility amid geopolitical fragmentation. The stability of this metric confirms the resilience of the asset's market capitalization.

Main competitors

Company Net Income Veeva Corp (VEEV)|DOCS (Doximity, Inc.) - Net Profit|Company Profit HQY (healthequity.com)|Net Profit WAY|Net Income CorVel Corp CRVL|Net Profit PRVA (Privia Health Corp)|Huron Corp (HURN) - Company Net Income|OMCL - Company Net Income|Final Profit GDRX (goodrx.com)|SDGR (Schrödinger) - Net Income|PHR: Profit After Payment of Taxes|OMDA (Omada Health Corp) - Net Profit|Net Profit Evolent Corp|Company Net Income HealthStream, Inc. (HSTM)|DH (definitivehc.com) - Final Profit|Net Profit CCSI (Consensus Cloud Solutions, Inc.)|Net Profit agilon health, inc. AGL|ABSI: Net Income|Final Profit SY (So-Young Corp)|NRC: Net Profit|SPOK - Net Financial Result|Company Net Income OptimizeRx|Company Profit TBRG (TruBridge Inc)|Net Profit SLP|Net Income sophiagenetics.com SOPH|Health Catalyst, Inc. - Net Income|Net Financial Result CareCloud Inc. (CCLD)|Research Solutions - Net Profit|DLH Holdings Corp. (DLHC) - Net Income|ONMD: Net Profit|Company Net Income Scienture Corp (SCNX)|Company Net Income Healthcare Triangle|ISPC: Final Profit|Net Income BFRG (Bullfrog AI Holdings)|Profit After Payment of Taxes WORX|Net Profit MSPR (LifeWallet)|Net Financial Result iCoreConnect, Inc. (ICCT)|MEDS: Net Income|orgenesis.com - Profit After Payment of Taxes|RCM (r1rcm.com) - Net Income|Sharecare Inc. - Final Profit|Company Net Income Streamline Health Solutions Inc.|Net Income Syra Health, Corp. (SYRA)|Net Profit AMEH|MODN - Company Net Income|Net Profit NXGN (NextGen Healthcare, Inc.)